Molecule Details
InChIKeyCJOFXWAVKWHTFT-XSFVSMFZSA-N
Compound NameFluvoxamine
Canonical SMILESCOCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Cross-Family
Avg pChEMBL8.18
SourceBindingDB;ChEMBL
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00176
Drug NameFluvoxamine
CAS Number54739-18-3
Groups approved investigational
ATC Codes N06AB08
DescriptionFluvoxamine is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor. Though it is in the same class as other SSRI drugs, it is most often used to treat obsessive-compulsive disorder. Fluvoxamine has been in use in clinical practice since 1983 and has a clin...

Categories: Amines Anti-Anxiety Agents Antidepressive Agents Antidepressive Agents Indicated for Depression Antidepressive Agents, Second-Generation BSEP/ABCB11 Substrates Central Nervous System Agents Central Nervous System Depressants Cytochrome P-450 CYP1A2 Inhibitors Cytochrome P-450 CYP1A2 Inhibitors (strong) Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP2B6 Inhibitors Cytochrome P-450 CYP2B6 Inhibitors (strength unknown) Cytochrome P-450 CYP2C19 Inhibitors Cytochrome P-450 CYP2C19 Inhibitors (strong) Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2C9 Inhibitors (moderate) Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP2D6 Inhibitors (moderate) Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (moderate) Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A7 Inhibitors Cytochrome P-450 CYP3A7 Inhibitors (moderate) Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Enzyme Inhibitors Hydroxylamines Hypoglycemia-Associated Agents Membrane Transport Modulators Nervous System Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Oximes P-glycoprotein inhibitors Psychoanaleptics Psychotropic Drugs Selective Serotonin Reuptake Inhibitors Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome Serotonin Agents Serotonin Modulators Tranquilizing Agents
Cross-references: BindingDB: 50028091 ChEBI: 5138 CHEMBL814 ChemSpider: 4481878 Drugs Product Database (DPD): 1212 C07571 PDB: FVX PharmGKB: PA449690 PubChem:3404 PubChem:46507588 RxCUI: 42355 Therapeutic Targets Database: DNC000897 Wikipedia: Fluvoxamine ZINC: ZINC000003872605
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
Q01959 SLC6A3 Homo sapiens Human PF00209 8.7 Ki ChEMBL;BindingDB
P31645 SLC6A4 Homo sapiens Human PF03491 PF00209 8.4 Ki ChEMBL;BindingDB
Q99720 SIGMAR1 Homo sapiens Human PF04622 7.4 Ki ChEMBL;BindingDB
DrugBank Target Actions (14)
Target Gene Target Name Action Type
P04798 CYP1A1 Cytochrome P450 1A1 inhibitor enzymes
P05177 CYP1A2 Cytochrome P450 1A2 inhibitor enzymes
P08684 CYP3A4 Cytochrome P450 3A4 inhibitor enzymes
P10635 CYP2D6 Cytochrome P450 2D6 inhibitor enzymes
P11712 CYP2C9 Cytochrome P450 2C9 inhibitor enzymes
P20813 CYP2B6 Cytochrome P450 2B6 inhibitor enzymes
P33261 CYP2C19 Cytochrome P450 2C19 inhibitor enzymes
P05177 CYP1A2 Cytochrome P450 1A2 substrate enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P10635 CYP2D6 Cytochrome P450 2D6 substrate enzymes
P31645 SLC6A4 Sodium-dependent serotonin transporter inhibitor targets
Q12809 KCNH2 Voltage-gated inwardly rectifying potassium channel KCNH2 inhibitor targets
P08183 ABCB1 ATP-dependent translocase ABCB1 inhibitor transporters
O95342 ABCB11 Bile salt export pump substrate transporters